Neuroinflammation, Neurodegeneration, and Depression

[1]  Feng Zhang,et al.  Resveratrol Protects Cortical Neurons against Microglia‐mediated Neuroinflammation , 2013, Phytotherapy research : PTR.

[2]  C. Pariante,et al.  Inflammation and depression. , 2013, Current topics in behavioral neurosciences.

[3]  W. Geldenhuys,et al.  Curcumin and neurodegenerative diseases: a perspective , 2012, Expert opinion on investigational drugs.

[4]  K. Manaye,et al.  Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar–Kyoto rats , 2012, Neuroscience.

[5]  Kevin Ellsworth,et al.  α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation , 2012, Journal of Neuroinflammation.

[6]  C. Metz,et al.  Nicotinic Acetylcholine Receptor Agonists Attenuate Septic Acute Kidney Injury in Mice by Suppressing Inflammation and Proteasome Activity , 2012, PloS one.

[7]  L. Antunes,et al.  Apoptotic neurodegeneration and spatial memory are not affected by sedative and anaesthetics doses of ketamine/medetomidine combinations in adult mice. , 2012, British journal of anaesthesia.

[8]  L. Price,et al.  The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development , 2012, TheScientificWorldJournal.

[9]  J. Segura-Aguilar,et al.  Protective Effects of Nicotine Against Aminochrome-Induced Toxicity in Substantia Nigra Derived Cells: Implications for Parkinson’s Disease , 2012, Neurotoxicity Research.

[10]  M. Mintun,et al.  Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder , 2012, Brain Stimulation.

[11]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[12]  James P. Herman,et al.  Stress, depression and Parkinson's disease , 2012, Experimental Neurology.

[13]  M. Kaster,et al.  Depressive-like behavior induced by tumor necrosis factor-α in mice , 2012, Neuropharmacology.

[14]  D. Dhawan,et al.  N-Methyl N-Nitrosourea Induced Functional and Structural Alterations in Mice Brain-Role of Curcumin , 2012, Neurotoxicity Research.

[15]  S. Hauser,et al.  Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF , 2011, Pharmacology Biochemistry and Behavior.

[16]  H. Kurihara,et al.  Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus. , 2011, The Journal of nutritional biochemistry.

[17]  K. Chopra,et al.  Curcumin ameliorates reserpine-induced pain–depression dyad: Behavioural, biochemical, neurochemical and molecular evidences , 2011, Psychoneuroendocrinology.

[18]  S. Kennedy,et al.  Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation , 2011, International review of psychiatry.

[19]  T. Hortobágyi,et al.  Depressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study , 2011, Dementia and Geriatric Cognitive Disorders.

[20]  Yumiko Yamane,et al.  Dementia with Lewy Bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer's disease , 2011, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[21]  A. Mobasheri,et al.  Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. , 2011, The Journal of biological chemistry.

[22]  S. Lakhan,et al.  Anti-inflammatory effects of nicotine in obesity and ulcerative colitis , 2011, Journal of Translational Medicine.

[23]  K. Kendler,et al.  Nicotine withdrawal-induced negative affect is a function of nicotine dependence and not liability to depression or anxiety. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[24]  Poonam Sharma,et al.  Hepatoprotective Effect of Curcumin on Lindane-induced Oxidative Stress in Male Wistar Rats , 2011, Toxicology international.

[25]  Sujata Singh,et al.  Ameliorative Potential of Quercetin Against Paracetamol-induced Oxidative Stress in Mice Blood , 2011, Toxicology international.

[26]  Cornelis J Van der Schyf,et al.  The use of multi-target drugs in the treatment of neurodegenerative diseases , 2011, Expert review of clinical pharmacology.

[27]  Cai Song,et al.  Cytokines mediated inflammation and decreased neurogenesis in animal models of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  Lisa Goehler,et al.  In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  R. Taylor,et al.  Toxic Effects of Low Alcohol and Nicotine Combinations in SH-SY5Y Cells are Apoptotically Mediated , 2011, Neurotoxicity Research.

[30]  L. Hurley,et al.  Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review , 2011, Neurotoxicity Research.

[31]  E. Neafsey,et al.  Neuroprotective preconditioning of rat brain cultures with ethanol: potential transduction by PKC isoforms and focal adhesion kinase upstream of increases in effector heat shock proteins , 2010, The European journal of neuroscience.

[32]  W. Streit,et al.  The Brain's Aging Immune System. , 2010, Aging and disease.

[33]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Alzheimer's Disease , 2010, Biological Psychiatry.

[34]  S. Hauser,et al.  Alcohol-induced depressive-like behavior is associated with cortical norepinephrine reduction , 2010, Pharmacology Biochemistry and Behavior.

[35]  A. Conti,et al.  Anaesthetic-Related Neuroprotection , 2010, CNS drugs.

[36]  R. Chang,et al.  The putative neurodegenerative links between depression and Alzheimer's disease , 2010, Progress in Neurobiology.

[37]  L. Price,et al.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature , 2010, Psychopharmacology.

[38]  Ying Xu,et al.  Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system , 2010, European Neuropsychopharmacology.

[39]  M. Rietschel,et al.  Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. , 2010, The American journal of psychiatry.

[40]  D. Bajic,et al.  Ketamine Activates Cell Cycle Signaling and Apoptosis in the Neonatal Rat Brain , 2010, Anesthesiology.

[41]  E. Neafsey,et al.  Moderate Ethanol Preconditioning of Rat Brain Cultures Engenders Neuroprotection Against Dementia-Inducing Neuroinflammatory Proteins: Possible Signaling Mechanisms , 2010, Molecular Neurobiology.

[42]  Ming D. Li,et al.  Nicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor , 2010, Journal of Neuroimmune Pharmacology.

[43]  P. Bickford,et al.  Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain. , 2010, Aging and disease.

[44]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[45]  K. Manaye,et al.  Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[46]  S. Maier,et al.  Memory impairments in healthy aging: Role of aging-induced microglial sensitization. , 2010, Aging and disease.

[47]  R. Lemos,et al.  Searching for New Genetic Risk Factors for Neuropsychiatric Disorders in Expression Databases , 2010, Journal of Molecular Neuroscience.

[48]  Zhaoxin Lu,et al.  Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. , 2009, International journal of food microbiology.

[49]  A. Mobasheri,et al.  Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1β-induced NF-κB-mediated inflammation and apoptosis , 2009, Arthritis research & therapy.

[50]  T. Patterson,et al.  Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain , 2009, International Journal of Developmental Neuroscience.

[51]  M. Quik,et al.  Multiple roles for nicotine in Parkinson's disease. , 2009, Biochemical pharmacology.

[52]  J. Zarranz,et al.  Application of depression criteria (DSM-IV) in patients with Parkinson's disease , 2009, Clinical Neurology and Neurosurgery.

[53]  John F. Cryan,et al.  “Killing the Blues”: A role for cellular suicide (apoptosis) in depression and the antidepressant response? , 2009, Progress in Neurobiology.

[54]  F. Yasuno,et al.  Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy , 2009, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[55]  Julie S. Jurenka.  Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. , 2009, Alternative medicine review : a journal of clinical therapeutic.

[56]  T. Connor,et al.  Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. , 2009, The international journal of neuropsychopharmacology.

[57]  I. Rozas.  Improving antidepressant drugs: update on recently patented compounds , 2009, Expert opinion on therapeutic patents.

[58]  F. Shi,et al.  Nicotine and inflammatory neurological disorders , 2009, Acta Pharmacologica Sinica.

[59]  Jing Du,et al.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. , 2009, The international journal of neuropsychopharmacology.

[60]  D. Overstreet,et al.  Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[61]  B. Leonard,et al.  The psychoneuroimmunology of depression , 2009, Human psychopharmacology.

[62]  J. Sheu,et al.  Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation , 2009, Mediators of inflammation.

[63]  A. Kimchi,et al.  Life and death partners: apoptosis, autophagy and the cross-talk between them , 2009, Cell Death and Differentiation.

[64]  J. Das,et al.  Additive Protective Effects of Donepezil and Nicotine Against Salsolinol-Induced Cytotoxicity in SH-SY5Y Cells , 2009, Neurotoxicity Research.

[65]  K. Siminovitch,et al.  The mDial Formin Is Required for Neutrophil Polarization, Migration, and Activation of the LARG/RhoA/ROCK Signaling Axis during Chemotaxis1 , 2009, The Journal of Immunology.

[66]  S. Kulkarni,et al.  Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes , 2009, Pharmacology Biochemistry and Behavior.

[67]  David B. Sattelle,et al.  Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection , 2009, Pharmacological Reviews.

[68]  G. Nair,et al.  Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.

[69]  E. Neafsey,et al.  Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. , 2009, Alcoholism, clinical and experimental research.

[70]  F. Shi,et al.  Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity1 , 2009, The Journal of Immunology.

[71]  J. Suls,et al.  Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.

[72]  R. Copeland,et al.  Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity , 2007, Neurotoxicity Research.

[73]  Brian E.Leonard,et al.  Inflammation and depression: Is there a causal connection with dementia? , 2006, Neurotoxicity Research.

[74]  Yasmine M. Kanaan,et al.  Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: Implications for parkinson’s disease , 2005, Neurotoxicity Research.

[75]  K. Manaye,et al.  Nicotine inhibits ethanol-induced toxicity in cultured cerebral cortical cells , 2009, Neurotoxicity Research.

[76]  K. Manaye,et al.  Nicotine blocks ethanol-induced apoptosis in primary cultures of rat cerebral cortical and cerebellar granule cells , 2009, Neurotoxicity Research.

[77]  K. Manaye,et al.  Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells , 2009, Neurotoxicity Research.

[78]  B. Aggarwal,et al.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. , 2009, The international journal of biochemistry & cell biology.

[79]  M. Maj,et al.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.

[80]  P. Davies,et al.  Therapeutic potential of resveratrol in Alzheimer's disease , 2008, BMC Neuroscience.

[81]  T. Simuni,et al.  Nonmotor manifestations of Parkinson's disease , 2008, Annals of neurology.

[82]  M. Banasr,et al.  Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors , 2008, Biological Psychiatry.

[83]  S. Hauser,et al.  Desipramine blocks alcohol-induced anxiety- and depressive-like behaviors in two rat strains , 2008, Pharmacology Biochemistry and Behavior.

[84]  M. Raskind.  Diagnosis and treatment of depression comorbid with neurologic disorders. , 2008, The American journal of medicine.

[85]  A. Zangen,et al.  Age‐dependent effects of chronic stress on brain plasticity and depressive behavior , 2008, Journal of neurochemistry.

[86]  M. Weiner,et al.  The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia , 2008, International journal of geriatric psychiatry.

[87]  F. Stella,et al.  Depression in patients with Parkinson's disease: Impact on functioning , 2008, Journal of the Neurological Sciences.

[88]  S. Kulkarni,et al.  Antidepressant activity of curcumin: involvement of serotonin and dopamine system , 2008, Psychopharmacology.

[89]  J. Kulisevsky,et al.  Motor changes during sertraline treatment in depressed patients with Parkinson’s disease * , 2008, European journal of neurology.

[90]  Jau-Shyong Hong,et al.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. , 2008, Trends in immunology.

[91]  I. Goshen,et al.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression , 2008, Molecular Psychiatry.

[92]  G. Bartzokis,et al.  Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[93]  Y. Kondo,et al.  Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells , 2008, Autophagy.

[94]  B. McEwen.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. , 2008, European journal of pharmacology.

[95]  Michal Gruberger,et al.  Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory , 2008, Brain, Behavior, and Immunity.

[96]  F. Gage,et al.  Mechanisms and Functional Implications of Adult Neurogenesis , 2008, Cell.

[97]  Guang Chen,et al.  Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors , 2008, Biological Psychiatry.

[98]  J. Koo,et al.  IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress , 2008, Proceedings of the National Academy of Sciences.

[99]  R. Zec,et al.  Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease. , 2008, NeuroRehabilitation.

[100]  M. Picciotto,et al.  Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[101]  D. Hedeker,et al.  Nicotine effects on affective response in depression-prone smokers , 2008, Psychopharmacology.

[102]  A. Steptoe,et al.  The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis , 2007, Brain, Behavior, and Immunity.

[103]  B. Leonard.  Inflammation, Depression and Dementia: Are they Connected? , 2007, Neurochemical Research.

[104]  B. Aggarwal,et al.  Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). , 2007, Free radical biology & medicine.

[105]  B. Aggarwal,et al.  Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. , 2007, Carcinogenesis.

[106]  Y. Chan,et al.  Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. , 2007, CNS and Neurological Disorders - Drug Targets.

[107]  Gwang Lee,et al.  Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action , 2007, The European journal of neuroscience.

[108]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[109]  B. Czéh,et al.  What causes the hippocampal volume decrease in depression? , 2007, European Archives of Psychiatry and Clinical Neuroscience.

[110]  Wei Li,et al.  Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. , 2007, Life sciences.

[111]  M. Thun,et al.  Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.

[112]  R. Drucker-Colín,et al.  Long-term changes in sleep and depressive symptoms of smokers in abstinence. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[113]  K. Unsicker,et al.  Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy , 2007, Experimental Neurology.

[114]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[115]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[116]  B. Spring,et al.  Influence of nicotine on positive affect in anhedonic smokers , 2007, Psychopharmacology.

[117]  E. Kua,et al.  Curry consumption and cognitive function in the elderly. , 2006, American journal of epidemiology.

[118]  F. Joseph McClernon,et al.  Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial , 2006, Psychopharmacology.

[119]  J. Langston,et al.  Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates , 2006, Journal of neurochemistry.

[120]  S. Gold,et al.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. , 2006, Neurologic clinics.

[121]  N. Rothwell,et al.  Neurodegenerative actions of interleukin‐1 in the rat brain are mediated through increases in seizure activity , 2006, Journal of neuroscience research.

[122]  Antonino Cattaneo,et al.  Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived Vertebrate , 2006, Current Biology.

[123]  C. Henchcliffe,et al.  Late-life depression: a neuropsychiatric approach , 2006, Expert review of neurotherapeutics.

[124]  D. Luckenbaugh,et al.  A double-blind, placebo-controlled study of memantine in the treatment of major depression. , 2006, The American journal of psychiatry.

[125]  F. Danner,et al.  Adolescent smoking and depression: which comes first? , 2006, Addictive behaviors.

[126]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[127]  H. Anisman,et al.  The pathogenesis of clinical depression: Stressor- and cytokine-induced alterations of neuroplasticity , 2005, Neuroscience.

[128]  Jane S. Paulsen,et al.  Depression and stages of Huntington's disease. , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[129]  Xue-jun Li,et al.  Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats , 2005, Pharmacology Biochemistry and Behavior.

[130]  L. Ulloa.  The vagus nerve and the nicotinic anti-inflammatory pathway , 2005, Nature Reviews Drug Discovery.

[131]  R. Papke,et al.  Multiple calcium channels and kinases mediate α7 nicotinic receptor neuroprotection in PC12 cells , 2005, Journal of neurochemistry.

[132]  Xue-jun Li,et al.  The effects of curcumin on depressive-like behaviors in mice. , 2005, European journal of pharmacology.

[133]  P. Kelly,et al.  Selective Neuron Loss in the Paraventricular Nucleus of Hypothalamus in Patients Suffering from Major Depression and Bipolar Disorder , 2005, Journal of neuropathology and experimental neurology.

[134]  F. Crews,et al.  TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition , 2005, Brain Research.

[135]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[136]  Deborah A. Yurgelun-Todd,et al.  Amygdala and hippocampus volumes in pediatric major depression , 2005, Biological Psychiatry.

[137]  R. Drucker-Colín,et al.  Effects of transderman nicotine on mood and sleep in nonsmoking major depresssed patients , 1995, Psychopharmacology.

[138]  F. Crews,et al.  TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. , 2005, Brain research.

[139]  C. Pomerleau,et al.  Euphoriant effects of nicotine in smokers , 2005, Psychopharmacology.

[140]  L. Barenghi,et al.  Cardiovascular protective effects of resveratrol. , 2006, Cardiovascular drug reviews.

[141]  Andrew H. Miller,et al.  Cytokines and psychopathology: Lessons from interferon-α , 2004, Biological Psychiatry.

[142]  J. Tiihonen,et al.  Dopamine and alcoholism: neurobiological basis of ethanol abuse , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[143]  K. Manaye,et al.  Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression , 2004, Neuropeptides.

[144]  E. Neafsey,et al.  Inhibition of amyloid-&bgr;-induced neurotoxicity and apoptosis by moderate ethanol preconditioning , 2004, Neuroreport.

[145]  R. Sapolsky.  Is impaired neurogenesis relevant to the affective symptoms of depression? , 2004, Biological Psychiatry.

[146]  T. Taniguchi,et al.  The Antiinflammatory Effects of Ketamine in Endotoxemic Rats During Moderate and Mild Hypothermia , 2004, Anesthesia and analgesia.

[147]  Qiang Liu,et al.  Nicotine attenuates β‐amyloid peptide‐induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures , 2004, British journal of pharmacology.

[148]  J. Godbout,et al.  Interleukin-6 in the aging brain , 2004, Journal of Neuroimmunology.

[149]  E. Corsini,et al.  Cytokines role in neurodegenerative events. , 2003, Toxicology letters.

[150]  S. Liljequist,et al.  Ethanol Differentially Inhibits Homoquinolinic Acid- and NMDA-Induced Neurotoxicity in Primary Cultures of Cerebellar Granule Cells , 2003, Neurochemical Research.

[151]  Andrew H. Miller,et al.  Cytokines and psychopathology: lessons from interferon-alpha. , 2004, Biological psychiatry.

[152]  M. Picciotto,et al.  Neuroprotection by Nicotine in Mouse Primary Cortical Cultures Involves Activation of Calcineurin and L-Type Calcium Channel Inactivation , 2003, The Journal of Neuroscience.

[153]  S. Wonnacott,et al.  Neuroprotection by nicotine against hypoxia-induced apoptosis in cortical cultures involves activation of multiple nicotinic acetylcholine receptor subtypes , 2003, Molecular and Cellular Neuroscience.

[154]  H. Kraemer,et al.  Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.

[155]  A. Nordberg,et al.  Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells , 2003, Neurochemistry International.

[156]  A. Steensberg,et al.  IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[157]  D. Fuchs,et al.  Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects , 2003 .

[158]  Yan Cui,et al.  EFFECTS OF KETAMINE/XYLAZINE ON EXPRESSION OF TUMOR NECROSIS FACTOR‐&agr;, INDUCIBLE NITRIC OXIDE SYNTHASE, AND CYCLO‐OXYGENASE‐2 IN RAT GASTRIC MUCOSA DURING ENDOTOXEMIA , 2003, Shock.

[159]  Yan Cui,et al.  Ketamine/xylazine attenuates LPS-induced iNOS expression in various rat tissues. , 2003, The Journal of surgical research.

[160]  A. Parrott.  Cigarette-Derived Nicotine is not a Medicine , 2003, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[161]  D. Fuchs,et al.  Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. , 2003, Current medicinal chemistry.

[162]  Y. Pollak,et al.  Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. , 2002, The international journal of neuropsychopharmacology.

[163]  H. Cohen,et al.  Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.

[164]  K. Brady,et al.  Cigarette smoking and psychiatric comorbidity in children and adolescents. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[165]  Odin van der Stelt,et al.  Neurochemical markers of alcoholism vulnerability in humans. , 2002, Alcohol and alcoholism.

[166]  G. Rajkowska.  Cell pathology in mood disorders. , 2002, Seminars in clinical neuropsychiatry.

[167]  Jerry W Rudy,et al.  Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus , 2002, Behavioural Brain Research.

[168]  P. Bickford,et al.  Diets Enriched in Foods with High Antioxidant Activity Reverse Age-Induced Decreases in Cerebellar β-Adrenergic Function and Increases in Proinflammatory Cytokines , 2002, The Journal of Neuroscience.

[169]  T. Kirkegaard,et al.  Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease , 2002 .

[170]  Y. Gupta,et al.  Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. , 2002, Life sciences.

[171]  D. Schulz,et al.  Prolonged effect of an anesthetic dose of ketamine on behavioral despair , 2002, Pharmacology Biochemistry and Behavior.

[172]  S. Wonnacott,et al.  Nicotine activates the extracellular signal‐regulated kinase 1/2 via the α7 nicotinic acetylcholine receptor and protein kinase A, in SH‐SY5Y cells and hippocampal neurones , 2002, Journal of neurochemistry.

[173]  M. Lynch.  Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. , 2002, Vitamins and hormones.

[174]  Zhirong Wang,et al.  Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. , 2002, International journal of molecular medicine.

[175]  S. Sachdeva,et al.  Prevalence of Dementia in an Urban Indian Population , 2001, International Psychogeriatrics.

[176]  F. Aloisi.  Immune function of microglia , 2001, Glia.

[177]  T. Taniguchi,et al.  Ketamine Inhibits Endotoxin-induced Shock in Rats , 2001, Anesthesiology.

[178]  S. DeKosky,et al.  Incidence of Alzheimer’s disease in a rural community in India , 2001, Neurology.

[179]  A. Glassman,et al.  Smoking cessation and the course of major depression: a follow-up study , 2001, The Lancet.

[180]  E. Neafsey,et al.  Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca2+-mediated neurotoxicity , 2001, Neuroscience.

[181]  T. S. Wilkinson,et al.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.

[182]  R. Kerwin,et al.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.

[183]  H. Kitamura,et al.  Brain interleukin-1 is involved in blood interleukin-6 response to immobilization stress in rats. , 2001, The Japanese journal of veterinary research.

[184]  H. Shibasaki,et al.  α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity* , 2001, The Journal of Biological Chemistry.

[185]  R. Locksley,et al.  The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.

[186]  J. W. Rudy,et al.  The immune system and memory consolidation: a role for the cytokine IL-1β , 2001, Neuroscience & Biobehavioral Reviews.

[187]  M. Maes.  The immunoregulatory effects of antidepressants , 2001, Human psychopharmacology.

[188]  H Shibasaki,et al.  alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. , 2001, The Journal of biological chemistry.

[189]  J. W. Rudy,et al.  The immune system and memory consolidation: a role for the cytokine IL-1beta. , 2001, Neuroscience and biobehavioral reviews.

[190]  H. Manji,et al.  Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. , 2001, Psychopharmacology bulletin.

[191]  H. Petrovitch,et al.  Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson’s Disease , 2001, Drugs & aging.

[192]  P. Allebeck,et al.  Alcoholism and depression in a Swedish female population: co‐morbidity andrisk factors , 2000, Acta psychiatrica Scandinavica.

[193]  R. Crum,et al.  Prospective study of depression and the risk of heavy alcohol use in women. , 2000, The American journal of psychiatry.

[194]  D. Overstreet,et al.  Depressive Characteristics of FSL Rats Involvement of Central Nicotinic Receptors , 2000, Pharmacology Biochemistry and Behavior.

[195]  E. Neafsey,et al.  HIV‐1 gp120 neurotoxicity in brain cultures is prevented by moderate ethanol pretreatment , 2000, Neuroreport.

[196]  C. Ellervik,et al.  Activity of tumour necrosis factor (TNF)-a converting enzyme (TACE) in colonic mucosa from patients with inflammatory bowel disease (IBD) , 2000 .

[197]  S. Hall,et al.  Development of major depression after treatment for smoking cessation. , 2000, The American journal of psychiatry.

[198]  A. Korten,et al.  Non-linear relationships in associations of depression and anxiety with alcohol use , 2000, Psychological Medicine.

[199]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[200]  N. Venkatesan,et al.  Curcumin prevents adriamycin nephrotoxicity in rats , 2000, British journal of pharmacology.

[201]  H. Ichinose,et al.  Changes in cytokines and neurotrophins in Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.

[202]  J. W. Rudy,et al.  Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation , 1999, Behavioural Brain Research.

[203]  D. Overstreet,et al.  Antidepressant Effect of Ingested Nicotine in Female Rats of Flinders Resistant and Sensitive Lines , 1999, Physiology & Behavior.

[204]  S. Jander,et al.  The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.

[205]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[206]  D. Overstreet,et al.  Antidepressant effects of nicotine in an animal model of depression , 1999, Psychopharmacology.

[207]  T. Horie,et al.  Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.

[208]  M. Miloso,et al.  Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? , 1999, Drugs under experimental and clinical research.

[209]  M. Maes,et al.  Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.

[210]  M. Lynch.  Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1β? , 1998, Progress in Neurobiology.

[211]  Yvette I. Sheline,et al.  Amygdala core nuclei volumes are decreased in recurrent major depression , 1998, Neuroreport.

[212]  S. Shimohama,et al.  Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity , 1998, Brain Research.

[213]  E. Bosmans,et al.  The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.

[214]  S. Maier,et al.  Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat , 1998, The Journal of Neuroscience.

[215]  M. Toru,et al.  Antidepressantlike Effects of Chronic Nicotine on Learned Helplessness Paradigm in Rats , 1998, Biological Psychiatry.

[216]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[217]  C. Dinarello,et al.  Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.

[218]  P. Wilson,et al.  Monocyte cytokine production in an elderly population: effect of age and inflammation. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.

[219]  S. Shimohama,et al.  Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. , 1998, Brain research.

[220]  B. Barton.  IL-6: insights into novel biological activities. , 1997, Clinical immunology and immunopathology.

[221]  G. Wakabayashi,et al.  Anti-inflammatory cytokine levels in patients with septic shock. , 1997, Research communications in molecular pathology and pharmacology.

[222]  Dinarello Ca,et al.  Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. , 1997 .

[223]  R. Yirmiya,et al.  Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins , 1997, Brain Research.

[224]  A. Glassman,et al.  Major depression following smoking cessation. , 1997, The American journal of psychiatry.

[225]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[226]  C. Dinarello,et al.  Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. , 1997, Journal of biological regulators and homeostatic agents.

[227]  D. Abrams,et al.  Development of major depressive disorder during smoking-cessation treatment. , 1996, The Journal of clinical psychiatry.

[228]  D. Donnelly-roberts,et al.  In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418 , 1996, Brain Research.

[229]  B. Barton,et al.  Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model , 1996, Infection and immunity.

[230]  J. Baron.  Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. , 1996, British Medical Bulletin.

[231]  M. Maes,et al.  The monocyte-T-lymphocyte hypothesis of major depression , 1995, Psychoneuroendocrinology.

[232]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[233]  G. Koob,et al.  Decreased brain reward produced by ethanol withdrawal. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[234]  David C. Hodgins,et al.  Prospective and retrospective reports of mood states before relapse to substance use. , 1995, Journal of consulting and clinical psychology.

[235]  E. Korpi,et al.  Ethanol inhibits NMDA-induced toxicity and trophism in cultured cerebellar granule cells. , 1995, Acta physiologica Scandinavica.

[236]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[237]  Michael Maes.  Cytokines in major depression , 1994, Biological Psychiatry.

[238]  W. Fiers,et al.  Response of interleukin‐6‐deficient mice to tumor necrosis factor‐induced metabolic changes and lethality , 1994, European journal of immunology.

[239]  H. Meltzer,et al.  Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobinemia during major depression , 1993, Psychiatry Research.

[240]  L. J. Chandler,et al.  Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. , 1993, Alcoholism, clinical and experimental research.

[241]  M. Maes.  Α Review on the Acute Phase Response in Major Depression , 1993, Reviews in the neurosciences.

[242]  R. Dantzer,et al.  Sickness behavior as a new target for drug development. , 1992, Trends in pharmacological sciences.

[243]  J. Cavaillon,et al.  Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.

[244]  E. Bosmans,et al.  Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. , 1990, Neuropsychobiology.

[245]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[246]  N. Harrison,et al.  Quantitative studies on some antagonists of N‐methyl D‐aspartate in slices of rat cerebral cortex , 1985, British journal of pharmacology.

[247]  Y. Oshima,et al.  Antihepatotoxic Principles of Curcuma longa Rhizomes1 , 1983, Planta medica.

[248]  P. Burch.  Cigarette smoking and Parkinson disease , 1981, Neurology.

[249]  R. Baumann,et al.  Cigarette smoking and Parkinson disease , 1980, Neurology.

[250]  O. P. Sharma.  Antioxidant activity of curcumin and related compounds. , 1976, Biochemical pharmacology.

[251]  M. Nefzger,et al.  A retrospective study of smoking in Parkinson's disease. , 1968, American journal of epidemiology.

[252]  H. Dorn.  Tobacco consumption and mortality from cancer and other diseases. , 1959, Acta - Unio Internationalis Contra Cancrum.